Lust, H., Schultz, L. M., Kwon, S., Roloff, G. W., Aldoss, I., Baggott, C., John, S., Rossoff, J., McNerney, K. O., Fabrizio, V. A., Talano, J.-A., Moskop, A., Curran, K. J., Phillips, C. L., Karras, N. A., Baumeister, S. H. C., Cooper, S., Hermiston, M. L., Satwani, P., … Faramand, R. G. (2025). Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014846

Eylon, M., Prabhu, S., John, S., King, M. J. M., Bhatt, D., Curran, K. J., Erickson, C., Karras, N. A., Phillips, C. L., Satwani, P., Hermiston, M., Southworth, E., Baumeister, S. H. C., Talano, J.-A., MacMillan, M. L., Rossoff, J., Bonifant, C. L., Myers, G. D., Rouce, R. H., … Schultz, L. M. (2023). Mediport use as an acceptable standard for CAR T cell infusion. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1239132

Shao, Z., Lee, B. J., Zhang, H., Lin, X., Li, C., Jiang, W., Chirathivat, N., Gershik, S., Shen, M. M., Baer, R., & Zha, S. (2023). Inactive PARP1 causes embryonic lethality and genome instability in a dominant-negative manner. Proceedings of the National Academy of Sciences, 120(31). https://doi.org/10.1073/pnas.2301972120